Menu
- About
- For Research Patients
- Para Pacientes
- For Investigators
- For Industry Sponsors
- K-12 Programs
- Leadership Development
close
Please contact us for more information or to learn if you are eligible to participate.
This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic and additional treatment strategies for prevention of adverse outcomes in COVID-19 positive inpatients.
Principal Investigator | Olabiyi Akala, MD |
Co-PI | Luis Cantu Jr. |
Sponsor | National Center for Advancing Translation Sciences |
Type of Trial | Interventional |